Wednesday, September 24, 2014

Kidneys for sale: debates about Iran and it's implications for markets in the West

As I indicated in my post yesterday, the conversation about compensating kidney donors is heating up. Various email correspondents brought to my attention the latest issue of the American Journal of Bioethics, which has a "target" article by Julian Koplin of Monash University and a number of responses and comments. Koplin argues that the experience of kidney sales in Iran should give pause to advocates of (even) regulated markets in the developed world. A number of the commentators argue that the evidence that he cites from Iran is now outdated, among other things. But the conclusions of the commentators are all over the map, from pro to anti and including appeals for allowing some experimentation to gather more evidence, and arguments against 'crossing the Rubicon' by allowing such trials.

I don't know of an ungated URL where you can read this, but of course if you have electronic access to a University library you can likely download it there.

Volume 14, Issue 10, 2014< Prev

The American Journal of Bioethics

ISSN
1526-5161 (Print), 1536-0075 (Online)
Publication Frequency 
12 issues per year
 

Editorial

Nancy S. Jecker
pages 1-6

  • DOI:10.1080/15265161.2014.953858
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 18

Target Article

Julian Koplin
pages 7-18

  • DOI:10.1080/15265161.2014.947041
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (16) 
  • Article Views: 15
Further Information

Open Peer Commentaries

I. Glenn Cohen
pages 19-21

  • DOI:10.1080/15265161.2014.947787
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 7

James Taylor
pages 21-22

  • DOI:10.1080/15265161.2014.947802
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 9

Alexander M. CapronGabriel M. Danovitch & Francis L. Delmonico
pages 23-25

  • DOI:10.1080/15265161.2014.947048
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 10

Alberto Giubilini
pages 25-27

  • DOI:10.1080/15265161.2014.947797
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 11

Erik Malmqvist
pages 27-29

  • DOI:10.1080/15265161.2014.947799
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 7

Samuel J. Kerstein
pages 29-30

  • DOI:10.1080/15265161.2014.947798
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 7

Benjamin Hippen
pages 31-33

  • DOI:10.1080/15265161.2014.947047
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 7

Monir Moniruzzaman
pages 33-35

  • DOI:10.1080/15265161.2014.947801
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 6

Kiarash Aramesh
pages 35-37

  • DOI:10.1080/15265161.2014.947044
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 8

Sigrid Fry-Revere
pages 37-38

  • DOI:10.1080/15265161.2014.947042
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 11

Miran Epstein
pages 39-40

  • DOI:10.1080/15265161.2014.947043
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 6

Atieh PajouhiFarzaneh ZahediZeinab Pajouhi & Bagher Larijani
pages 40-42

  • DOI:10.1080/15265161.2014.947443
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 6

Ryan Tonkens
pages 42-44

  • DOI:10.1080/15265161.2014.947046
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 7

Julie AllardAviva Goldberg & Marie-Chantal Fortin
pages 44-45

  • DOI:10.1080/15265161.2014.947442
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 7

Dominique Martin & Sarah White
pages 46-48

  • DOI:10.1080/15265161.2014.947045
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 7

No comments: